Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 February 2022 | Story Lacea Loader

From 24 February 2022 – as an interim solution to the challenges experienced with the disruption of classes on the University of the Free State (UFS) Bloemfontein Campus during the week of 21 February 2022 – the academic programme will continue in a differentiated and flexible online mode in some modules within faculties.

Face-to-face classes will continue in those modules where online teaching is not possible at this stage. Students will be informed by their respective faculties as to which modules will be moving online, and which will remain face to face.

This is a temporary measure to enable the campus to return to stability. The arrangement is estimated to continue for two to three weeks at the most, after which the academic programme will return to the approved teaching plans for 2022.

As an additional measure and to mitigate the challenges of remote off-campus internet access, 10 GB of data is provided free of charge through Global Protect to all registered students for the next month. This will enable students to link to learning resources off campus at no cost. The use of social media is, however, not included in the 10 GB.

Enquiries regarding GlobalProtect can be directed to the ICT Services Call Centre at +27 51 401 9111 (option 4).

Computer laboratories on the campus will remain available to vaccinated students whose modules will be moving online.

Issued by:
Lacea Loader
Director: Communication and Marketing
University of the Free State
loaderl@ufs.ac.za

23 February 2022

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept